Healthcare Policy

CMS Ignores Seniors in 340B Cuts, Paving Way for Insurer Windfalls

While the Centers for Medicare & Medicaid Services claims cost savings, new payment proposals could hit seniors' wallets and access to care, a reality lost in the mainstream coverage.

By Neil D'Monte, Palmelle Editorial Team · Reviewed by Neil D'Monte · 7 min read · 2026-07-05

SHORT ANSWER

CMS's proposed 2027 payment changes for hospitals and Medicare Advantage could increase costs for seniors and reduce access to discounted drugs at safety-net hospitals, despite mainstream coverage focusing on insurer benefits.

The direct answer

The Centers for Medicare & Medicaid Services (CMS) has proposed significant changes to hospital outpatient payments set to take effect in 2027. While CMS frames these as necessary cost-cutting measures, the proposed cuts to 340B drug pricing and the expansion of site-neutral policies for hospital outpatient services could disproportionately affect seniors. Safety-net hospitals, which rely on 340B discounts to provide care to underserved populations, may see reduced access to these crucial savings

Medicare Advantage just got a massive cash injection 💰 Trump admin finalizes Star Ratings overhaul — $18B in extra payments flowing to health insurers. This is a direct tailwind for the big MA players: $UNH , $HUM , $CVS , $ELV , $CNC all stand to benefit from higher reimbursement…
— Casey | Trade Tracs link

. Furthermore, site-neutral policies, which aim to pay different rates for the same service depending on the facility type, could increase out-of-pocket costs for seniors receiving common imaging and diagnostic services at hospital outpatient departments, rather than physician offices

Everything you need to know about the CMS news, and what it means for $UNH and $OSCR : $UNH surged after CMS finalized a much better-than-expected Medicare Advantage rate update for 2027. The headline rate came in at +2.48%, far above the +1.0% many were bracing for, and CMS…
— Stocker-Man link

. The narrative pushed by CMS and some media outlets focuses on system-wide savings, but overlooks the direct financial implications for beneficiaries and the providers serving them.

The 340B Disconnect: Savings for Whom?

The proposed cuts to 340B drug payments are presented by CMS as a way to curb program "overutilization." However, this overlooks the fundamental purpose of 340B: to allow safety-net providers, including many hospitals serving low-income and rural communities, to purchase outpatient drugs at a significant discount and pass those savings onto patients. Reducing these discounts directly impacts these providers' ability to offer essential services and affordable care. The narrative of "cost-cutting" conveniently sidesteps the reality that these cuts could lead to higher drug costs for patients at these critical facilities, potentially forcing them to seek care elsewhere, if they can

Medicare Advantage just got a massive cash injection 💰 Trump admin finalizes Star Ratings overhaul — $18B in extra payments flowing to health insurers. This is a direct tailwind for the big MA players: $UNH , $HUM , $CVS , $ELV , $CNC all stand to benefit from higher reimbursement…
— Casey | Trade Tracs link

. This isn't about system efficiency; it's about redirecting funds away from patient care and towards the bottom lines of larger entities.

Site-Neutral Policies: A Trojan Horse for Higher Co-pays

The expansion of site-neutral policies, a long-standing industry push, is being pitched as a way to equalize payment rates between hospital outpatient departments and physician offices for similar services, particularly common imaging and diagnostic procedures. While the stated aim is to reduce overall Medicare spending, the immediate consequence for beneficiaries could be higher out-of-pocket costs. Many seniors face co-insurance or co-pays based on a percentage of the Medicare payment. If the payment rate for a service performed in a hospital outpatient setting is reduced to match that of a physician's office, but the patient's out-of-pocket responsibility remains a percentage of that lower rate, their actual dollar cost could decrease. However, the industry narrative often implies higher costs for hospitals, which can translate to higher patient costs if not managed carefully

Everything you need to know about the CMS news, and what it means for $UNH and $OSCR : $UNH surged after CMS finalized a much better-than-expected Medicare Advantage rate update for 2027. The headline rate came in at +2.48%, far above the +1.0% many were bracing for, and CMS…
— Stocker-Man link

. This policy shift could also incentivize shifting services away from hospitals, potentially impacting access in underserved areas.

Medicare Advantage's Sweetheart Deal

While CMS rolls out proposals that could complicate care for seniors, it simultaneously finalized payment policies for Medicare Advantage (MA) plans that are proving incredibly lucrative for insurers. The finalized 2027 MA payment rates project a net average increase of 2.48%, translating to over $13 billion in additional payments to MA plans

CMS finalized its 2027 Medicare Advantage and Part D payment policies, projecting a net average 2.48% increase, or more than $13B in additional MA payments. The agency will also keep the 2024 MA risk adjustment model and exclude most unlinked chart review diagnoses from risk…
— Wall St Engine link

. This comes on the heels of a "Star Ratings overhaul" that injected an estimated $18 billion into MA plans during the Trump administration

Medicare Advantage just got a massive cash injection 💰 Trump admin finalizes Star Ratings overhaul — $18B in extra payments flowing to health insurers. This is a direct tailwind for the big MA players: $UNH , $HUM , $CVS , $ELV , $CNC all stand to benefit from higher reimbursement…
— Casey | Trade Tracs link

. This significant financial tailwind for major MA players like UnitedHealth Group ($UNH), Humana ($HUM), and CVS Health ($CVS) [c1, c3] starkly contrasts with the potential financial pressures on seniors and safety-net providers stemming from the proposed 340B and site-neutral changes. The market reaction, with $UNH surging after hours following the MA payment news

🚨 BREAKING: CMS finalizes 2027 Medicare Advantage payments with a 2.48% rate increase $UNH +10% in after hours
— TrendSpider link

, underscores who truly benefits from these CMS decisions.

A SCENE

Eleanor, 78, lives on a fixed income in a rural area and relies on the local community health center for her chronic condition management. This center is a designated 340B provider, allowing her to afford her essential heart medication at a significantly reduced price. She also recently had a routine ultrasound at the center's outpatient clinic, a service her Medicare Part B covers. The CMS proposals, however, cast a shadow over her healthcare future. If the 340B discounts are slashed, her medication co-pay could jump from $10 to $30, a sum that would require difficult choices elsewhere in her budget. Simultaneously, the proposed site-neutral payment adjustments for outpatient imaging could mean her $50 co-pay for the ultrasound might not change, or worse, could increase if the hospital's negotiated rates are altered in a way that shifts more cost to her. Meanwhile, her neighbor, who is enrolled in a Medicare Advantage plan that recently saw its insurer receive a significant payment boost from CMS, is discussing how her plan benefits seem to be expanding, a stark contrast to Eleanor's growing concerns about access and affordability.

Common mistakes

Framing CMS proposals as purely cost-saving without detailing the impact on seniors.
The mainstream coverage often echoes CMS's narrative of budget efficiency, failing to investigate the downstream financial consequences for beneficiaries and safety-net providers, a crucial element for understanding the true cost of these policies.
Ignoring the direct financial benefit to Medicare Advantage insurers concurrent with proposed cuts to patient-facing programs.
The simultaneous finalization of favorable MA payment rates and proposed cuts to 340B/site-neutral policies creates a significant disconnect. Highlighting the MA windfall provides essential context for understanding the broader financial landscape and who benefits most from CMS's actions.
Failing to connect site-neutral policies to potential out-of-pocket cost increases for seniors.
While site-neutrality aims to equalize payments, its impact on patient co-pays and co-insurance, which are often percentage-based, is rarely explored. This oversight misses a critical point of financial exposure for seniors receiving common outpatient services.

PALMELLE'S VIEW

In our view, CMS's latest proposals are a classic example of regulatory misdirection. By framing cuts to the 340B drug discount program and the expansion of site-neutral payments as mere 'cost-saving' measures, they mask the real impact on vulnerable populations, particularly seniors who rely on safety-net providers. The immediate surge in Medicare Advantage stocks following related payment finalizations [c2, c4] tells a different story – one of a massive cash injection for insurers, not relief for patients. This policy shift, cloaked in bureaucratic language, risks widening healthcare disparities and increasing out-of-pocket expenses for those least able to afford it.

BOTTOM LINE

Ask your healthcare provider if they are a 340B participant and how proposed CMS payment changes might affect your medication costs and outpatient service co-pays.

WHEN THIS CHANGES

The impact of these CMS proposals will become clearer as final rules are published and implemented, likely by January 1, 2027. Changes in Medicare Advantage payment rates are typically updated annually. Any shifts in out-of-pocket costs will depend on specific insurance plan structures and provider billing practices following the implementation of these new policies.

Frequently asked

What is the 340B drug discount program?

The 340B program requires drug manufacturers to provide outpatient drugs to eligible healthcare facilities and entities at significantly reduced prices. These savings are intended to help these providers, often serving low-income or uninsured patients, stretch their limited resources further and offer more comprehensive services.

What are site-neutral payments?

Site-neutral payments refer to policies that aim to pay the same rate for a service regardless of where it is performed (e.g., a hospital outpatient department versus a physician's office). The goal is to reduce healthcare costs by eliminating payment disparities based solely on the facility's type.

How might these CMS proposals affect my healthcare costs?

If you rely on safety-net hospitals for medications, 340B cuts could increase your drug costs. If you receive services like imaging at hospital outpatient departments, site-neutral policies could alter your out-of-pocket expenses, potentially increasing them depending on your insurance plan and the specific service.

CMS Ignores Seniors in 340B Cuts, Paving Way for Insurer Windfalls

The direct answer

The 340B Disconnect: Savings for Whom?

Site-Neutral Policies: A Trojan Horse for Higher Co-pays

Medicare Advantage's Sweetheart Deal

Common mistakes

Frequently asked

Sources

Keep reading